FNI Stock Overview
Operates in the health, happiness, wealth, and intelligent manufacturing sectors in Mainland China, Portugal, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
Fosun International Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.50 |
| 52 Week High | HK$0.73 |
| 52 Week Low | HK$0.44 |
| Beta | 0.85 |
| 11 Month Change | -7.69% |
| 3 Month Change | 6.21% |
| 1 Year Change | -9.79% |
| 33 Year Change | -49.68% |
| 5 Year Change | -58.35% |
| Change since IPO | -50.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| FNI | DE Industrials | DE Market | |
|---|---|---|---|
| 7D | -1.8% | -6.4% | -1.3% |
| 1Y | -9.8% | 17.4% | 7.4% |
Return vs Industry: FNI underperformed the German Industrials industry which returned 17.4% over the past year.
Return vs Market: FNI underperformed the German Market which returned 7.4% over the past year.
Price Volatility
| FNI volatility | |
|---|---|
| FNI Average Weekly Movement | 8.7% |
| Industrials Industry Average Movement | 4.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: FNI's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: FNI's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 109,000 | Qiyu Chen | www.fosun.com |
Fosun International Limited operates in the health, happiness, wealth, and intelligent manufacturing sectors in Mainland China, Portugal, and internationally. It operates through five segments: Health, Happiness, Insurance, Asset Management, and Intelligent Manufacturing. The Health segment engages in the research, development, manufacture, sale, and trading of pharmaceutical and health products; and provision of medical and health management services.
Fosun International Limited Fundamentals Summary
| FNI fundamental statistics | |
|---|---|
| Market cap | €4.23b |
| Earnings (TTM) | €97.86m |
| Revenue (TTM) | €26.37b |
43.2x
P/E Ratio0.2x
P/S RatioIs FNI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FNI income statement (TTM) | |
|---|---|
| Revenue | CN¥198.97b |
| Cost of Revenue | CN¥116.95b |
| Gross Profit | CN¥51.41b |
| Other Expenses | CN¥50.67b |
| Earnings | CN¥738.39m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.09 |
| Gross Margin | 25.84% |
| Net Profit Margin | 0.37% |
| Debt/Equity Ratio | 108.6% |
How did FNI perform over the long term?
See historical performance and comparison